Back to CHARLES SCHWAB INVESTMENT MANAGEMENT INC CHARLES SCHWAB INVESTMENT MANAGEMENT INC

OCULOCUL
Showing 8 of 31 quarters

Position history for CHARLES SCHWAB INVESTMENT MANAGEMENT INCCHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in OCULAR THERAPEUTIX INC

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds 1.5M shares of OCUL (OCULAR THERAPEUTIX INC), worth $15.1M as of 2026-Q2. The position was increased (+5.0% shares). OCUL represents 0.0% of CHARLES SCHWAB INVESTMENT MANAGEMENT INC's portfolio.

Current Value

$15.1M

Current Shares

1.5M

Total Value Change

+$5.4M

Total Shares Change

+422,978

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.5M
+5.0%
$15.1M0.0%$9.82
30
2026-Q1
Increased
1.5M
+0.1%
$12.4M0.0%$10.76
28
2025-Q4
Increased
1.5M
+29.9%
$17.7M0.0%$12.20
36
2025-Q3
Increased
1.1M
+2.6%
$13.1M0.0%$12.53
29
2025-Q2
Decreased
1.1M
-1.6%
$10.2M0.0%$9.22
0
2025-Q1
Decreased
1.1M
-1.6%
$8.2M0.0%$7.58
0
2024-Q4
Increased
1.1M
+1.9%
$9.7M0.0%$8.35
28
2024-Q3
Increased
1.1M
+146.6%
$9.7M0.0%$8.68
45

Other major holders of OCUL: FMR LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used